Akbulut Sami, Arer Ilker, Kocbiyik Alper, Yağmurdur Mahmut Can, Karakayalı Hamdi, Haberal Mehmet
Department of Surgery, University Hospital of Baskent, Ankara 06490, Turkey.
Int Semin Surg Oncol. 2009 Feb 5;6:4. doi: 10.1186/1477-7800-6-4.
This retrospective study analysed the epidemiological, clinical, and therapeutic profiles of breast cancer in males.
We report our experience at the Hospital of the University of Baskent, where 20 cases of male breast cancer were observed and treated between 1995-2008.
Median age at presentation was 66,7 +/- 10,9 years. Average follow-up was 63 +/- 18,5 months. The main presenting symptom was a mass in 65% of cases (13 patients). Ynvasive ductal carcinoma was the most frequent pathologic type (70% of cases).
Male breast cancer patients have an incidence of prostate cancer higher than would be predicted in the general population. Cause of men have a higher rate of ER positivity the responses with hormonal agents are good.
这项回顾性研究分析了男性乳腺癌的流行病学、临床和治疗特征。
我们报告了在巴斯肯特大学医院的经验，1995年至2008年间在该医院观察并治疗了20例男性乳腺癌患者。
就诊时的中位年龄为66.7±10.9岁。平均随访时间为63±18.5个月。主要表现症状为肿块的病例占65%（13例患者）。浸润性导管癌是最常见的病理类型（病例的70%）。
男性乳腺癌患者前列腺癌的发病率高于一般人群的预期。由于男性雌激素受体阳性率较高，对激素药物的反应良好。
